4/A: Mural Oncology Director Altschuller Corrects Option Price in Amended SEC Filing

Susan Altschuller, a director at Mural Oncology plc, filed an amendment to a previous Form 4 to correct the price of a stock option granted on May 30, 2024.

Summary

• Susan Altschuller, a director of Mural Oncology plc, filed an amended Form 4 with the SEC.
• The amendment corrects a scrivener's error in the originally reported price of a stock option.
• The stock option, granted on May 30, 2024, allows Altschuller to buy 8,462 ordinary shares at a price of $3.35.
• The option vests on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting, contingent on continued service with the Issuer.
• The corrected price is reflected as $0.00 in the filing.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate any significant positive or negative developments for the company, hence a neutral sentiment score.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency regarding stock options granted to directors.

Stakeholder Impact

• The correction of the stock option price ensures accurate information for shareholders.

Key Dates